Earnings Expansion Will Continue Despite Shifting Market Expectations And Margin Pressure

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

08 Dec 24

Updated

11 Dec 25

Views

63

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

7.1%

7D

1.9%

Loading

1Y

7.1%

7D

1.9%

You can edit this narrative until Dec 12 5:05 PM. Then, changes will post as Updates.

Author's Valuation

€74.478.1% undervalued

AnalystConsensusTarget Fair Value

Shared on 11 Dec 25

Fair value Increased 0.90%

AMUN: Distribution Partnerships And Earnings Guidance Will Shape Future Performance Balance

Amundi's analyst price target has inched higher by about EUR 0.70 to EUR 74.50, as analysts modestly upgrade fair value assumptions and future earnings expectations despite continued uncertainty around distribution agreements. Analyst Commentary Recent research updates present a mixed but generally constructive view on Amundi, with price targets moving both higher and lower as analysts reassess growth, distribution risks, and valuation.

Shared on 27 Nov 25

Fair value Increased 0.81%

AMUN: Distribution Partnerships And Earnings Resilience Will Define Near-Term Performance

Amundi's analyst price target was raised modestly from EUR 73.21 to EUR 73.80. This reflects analysts' continued confidence in the company's outlook despite recent sector volatility and mixed target adjustments across the Street.

Shared on 13 Nov 25

Fair value Decreased 3.34%

AMUN: Distribution Agreement Uncertainty And Profit Margin Outlook Will Shape Performance

Amundi’s analyst price target has decreased to €73.21 from €75.74. Analysts cite diminished outlook confidence and persistent uncertainty regarding key distribution agreements.

Shared on 29 Oct 25

Fair value Decreased 1.02%

Amundi's analyst price target has been modestly reduced from €76.52 to €75.74. Analysts cite recent adjustments in growth assumptions and market expectations, which support the new valuation.

Shared on 01 May 25

Fair value Decreased 0.30%

Shared on 23 Apr 25

Fair value Decreased 47%

AnalystConsensusTarget has decreased revenue growth from 1.5% to -18.3%.

Shared on 17 Apr 25

Fair value Decreased 1.48%

AnalystConsensusTarget has decreased revenue growth from 1.7% to 1.5%.

Shared on 09 Apr 25

Fair value Decreased 2.41%

AnalystConsensusTarget has decreased revenue growth from 2.8% to 1.7%.

Shared on 02 Apr 25

Fair value Increased 1.29%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 0.51%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 88%

AnalystConsensusTarget has increased revenue growth from -18.3% to 2.8% and increased shares outstanding growth rate from -0.0% to 0.0%.

AnalystConsensusTarget Fair Value

€74.47

8.1% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

-15.75%

Capital Markets revenue growth rate

0.25%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

11.37%

Calculation

€1.37b

Earnings '28

x

15.40x

PE Ratio '28

=

€21.10b

Market Cap '28

€21.10b

Market Cap '28

/

204.80m

No. shares '28

=

€103.01

Share Price '28

€103.01 Share Price '28

Discounted to 2025 @ 11.57% p.a.

=

€74.18

Fair Value '25